Drugs
-
Saquinavir (marketed as Invirase) Information
-
Related Information
FDA Drug Safety Podcast for Healthcare Professionals: Invirase (saquinavir) labels now contain updated risk information on abnormal heart rhythms FDA Drug Safety Communication: Invirase (saquinavir) labels now contain updated risk information on abnormal heart rhythms
10/21/2010New Label Changes for Commonly Prescribed HIV Drug Invirase
10/21/2010FDA Drug Safety Communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms
2/23/2010FDA Announces Possible Safety Concern for HIV Drug Combination
2/23/2010Podcast for Healthcare Professionals:Ongoing Safety Review of Invirase and Possible Association with Abnormal Heart Rhythms
2/25/2010
-
-
Labeling and Regulatory History from Drugs@FDA
-
-
-